Effectiveness of physical exercise for people with chronic diseases: the EFIKRONIK study protocol for a hybrid, clinical and implementation randomized trial

被引:9
作者
Arietaleanizbeaskoa, Maria Soledad [1 ]
Sancho, Aintzane [2 ]
Olazabal, Inigo [3 ]
Moreno, Concepcion [4 ]
Gil, Erreka [1 ]
Garcia-Alvarez, Arturo [1 ]
Mendizabal, Nere [1 ]
de la Fuente, Ibon [1 ]
Dominguez, Silvia [1 ]
Pablo, Susana [1 ]
Grandes, Gonzalo [1 ]
机构
[1] Biocruces Bizkaia Hlth Res Inst, Primary Care Grp Hlth Prevent & Chron Dis, Plaza Cruces 12, Bizkaia 48903, Spain
[2] Biocruces Bizkaia Hlth Res Inst, Med Oncol Grp, Plaza Cruces 12, Baracaldo 48903, Bizkaia, Spain
[3] Biocruces Bizkaia Hlth Res Inst, Med Hematol Grp, Plaza Cruces 12, Baracaldo 48903, Bizkaia, Spain
[4] Biocruces Bizkaia Hlth Res Inst, Med Mental Hlth Grp, Plaza Cruces 12, Baracaldo 48903, Bizkaia, Spain
关键词
Chronic diseases; Physical activity; Functional capacity; Quality of life; Primary care; SEDENTARY BEHAVIOR; LACTATE THRESHOLD; INTERVENTIONS; METAANALYSIS; GUIDELINES; RESISTANCE; COPD; 1ST;
D O I
10.1186/s12875-020-01298-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundChronic illnesses are the leading cause of morbidity and mortality and threaten the sustainability of healthcare systems worldwide. There is limited evidence in terms of the best modality and intensity of physical activity for improving cardiorespiratory capacity and quality of life in patients with chronic conditions. The objective of the EfiKroniK study is to estimate the common effect of innovative, individualized and supervised physical exercise, on cardiorespiratory functional capacity and quality of life across people with different chronic conditions.Methods/designThis is a multicentre clinical trial with a type I hybrid effectiveness-implementation design, including 370 patients each with one of four different chronic illnesses: solid cancer, blood cancer, chronic obstructive pulmonary disease or schizophrenia. Patients will be randomly divided into two parallel groups, stratified by illness type. Patients in both groups will receive a standard healthy life prescription (PVS, from the Spanish "Prescribe Vida Saludable") and additionally, the EfiKroniK group will be prescribed a physical exercise programme tailored to each patient in terms of intensity in each session. The primary outcome variables will be cardiorespiratory functional capacity and quality of life. The secondary outcome variables will be signs and symptoms, psychological and social factors and specific laboratory parameters. We will also analyse the dose-response effect of the physical exercise programme. Qualitative variables will describe patients' perception of the utility and suitability of the EfiKroniK programme, as well as their expectations and satisfaction, identifying barriers to and facilitators of the EfiKroniK implementation process through discussion groups. The study will be carried out on an intention-to-treat basis, comparing changes throughout the 1-year follow-up between groups, adjusting for baseline, by performing mixed-effect analysis of covariance. We will estimate the effect of time on repeated measures in each subject and changes in the EfiKroniK and PVS groups over time.DiscussionThe study will provide the data necessary to allow us to prescribe physical exercise in a similar way to a drug and as a key part of the treatment of chronic illnesses within our healthcare system.Trial registrationNCT03810755.Date and version identifier: October 9, 2020. Version2.0.
引用
收藏
页数:11
相关论文
共 44 条
[1]   Reporting and Replicating Trials of Exercise-Based Cardiac Rehabilitation Do We Know What the Researchers Actually Did? [J].
Abell, Bridget ;
Glasziou, Paul ;
Hoffmann, Tammy .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (02) :187-+
[2]   Effects and prevalence of nonresponders after 12 weeks of high-intensity interval or resistance training in women with insulin resistance: a randomized trial [J].
Alvarez, Cristian ;
Ramirez-Campillo, Rodrigo ;
Ramirez-Velez, Robinson ;
Izquierdo, Mikel .
JOURNAL OF APPLIED PHYSIOLOGY, 2017, 122 (04) :985-996
[3]  
[Anonymous], 2018, 2018 PHYS ACT GUID C
[4]  
Battaglini CL, 2011, RECENT RESULTS CANC, V186, P275, DOI 10.1007/978-3-642-04231-7_12
[5]   Maximal lactate steady state concentration (MLSS): experimental and modelling approaches [J].
Beneke, R .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2003, 88 (4-5) :361-369
[6]   Blood Lactate Diagnostics in Exercise Testing and Training [J].
Beneke, Ralph ;
Leithaeuser, Renate M. ;
Ochentel, Oliver .
INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE, 2011, 6 (01) :8-24
[7]  
Bengoa R, 2013, INT J INTEGR CARE, V13
[8]   Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing [J].
Binder, Ronald K. ;
Wonisch, Manfred ;
Corra, Ugo ;
Cohen-Solal, Alain ;
Vanhees, Luc ;
Saner, Hugo ;
Schmid, Jean-Paul .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (06) :726-734
[9]  
Birken SA, 2017, IMPLEMENT SCI IS, P12
[10]   PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION [J].
BORG, GAV .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) :377-381